Promising Studies In Prostate Cancer | A 2021 ASCO Update | Mark Scholz, MD

Medical Oncologist Mark Scholz, MD discusses three promising studies on advanced prostate cancer that were presented at ASCO 2021 — the meeting for the American Society of Clinical Oncologists. 0:42 Lupron plus Zytiga (abiraterone) plus Taxotere (docetaxel) in men with metastatic castrate-sensitive disease. meetinglibrary.asco.org/record/196406/abstract www.urotoday.com/conference-highlights/asco-2021/a… 3:08 Xofigo (a radiopharmaceutical) and Xtandi with the bone protecting agent Xgeva. meetinglibrary.asco.org/record/196744/abstract www.urotoday.com/conference-highlights/asco-2021/a… 5:41 Using high-dose testosterone and Opdivo in men who are becoming resistant to treatment with hormone therapy. meetinglibrary.asco.org/record/196410/abstract www.urotoday.com/conference-highlights/asco-2021/a… Don’t know your stage? Take the quiz: Visit www.prostatecancerstaging.org/ To learn more about prostate cancer visit www.pcri.org/ Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #ProstateCancer #MarkScholzMD #Prostate